Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Affymetrix Inc.
Affymetrix Reports First Quarter 2008 Results
May 11th, 2008
Affymetrix Inc., (Nasdaq:AFFX) reported its operating results for the first quarter of 2008. Total revenue for the quarter was $169.6 million, including an intellectual property payment of $90 million, as compared to total revenue of $80.4 million in the first quarter of 2007. Product revenue was $62.8 million, which consists of array and reagent revenue of $58.8 million and instrument revenue of $4.0 million. Service revenue was $8.4 million, and royalties and other revenue were $98.3 million for the first quarter of 2008. This compares to first quarter 2007 product revenue of $64.5 million. Service revenue was $8.8 million, and royalties and other revenue were $7.2...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-11)
|
